CSRXP: OUTRAGEOUS PRICE TAG ON NEW DIABETES DRUG LATEST EXAMPLE OF BIG PHARMA’S OUT-OF-CONTROL LAUNCH PRICES
Nov 21, 2022
Drug Company Sets Nearly $200,000 Price on Newly Approved Treatment for Type 1… Read More
© 2025 CSRXP- All Rights Reserved
Press & Statements
CSRXP APPLAUDS FDA APPROVAL OF SECOND INTERCHANGEABLE BIOSIMILAR FOR INSULIN
Nov 18, 2022
Interchangeable Biosimilars Help Provide Patients with Greater Choice and More… Read More
CSRXP: PFIZER’S EGREGIOUS VACCINE PRICE HIKE DEMONSTRATES URGENCY TO BUILD ON POSITIVE PROGRESS TO HOLD BIG PHARMA ACCOUNTABLE
Oct 21, 2022
Big Pharma Companies Want to Price-Gouge the American People and Health Care… Read More
CSRXP: BIG PHARMA’S EGREGIOUS $158,000 PRICE TAG ON UNPROVEN ALS TREATMENT MIRRORS PRICE-GOUGING OF ADUHELM
Oct 6, 2022
Brand Name Drug Maker Amylyx Sets Price Tag For Relyvrio Between Five And 17… Read More
CSRXP: AMERICAN PATIENTS COUNTING ON CONGRESS TO BUILD ON POSITIVE PROGRESS TOWARD LOWERING DRUG PRICES, NOT GO BACKWARDS
Sep 26, 2022
Lawmakers Must Put Patients First And Reject Bogus Big Pharma Rhetoric… Read More
CSRXP: MODERNA MUST BE PUT ON NOTICE THAT PATIENTS, POLICYMAKERS WOULD FIND SIX-FOLD VACCINE PRICE HIKE UNCONSCIONABLE
Sep 12, 2022
Big Pharma Giant Eyes Massive Price Hike on COVID-19 Vaccine Developed with… Read More
CSRXP APPLAUDS PRESIDENT BIDEN FOR TAKING MAJOR STEP TOWARD HOLDING BIG PHARMA ACCOUNTABLE
Aug 16, 2022
Biden Administration and Congress Deliver Positive Progress on Longstanding… Read More
CSRXP: CONGRESS TAKES MAJOR STEP TOWARD HOLDING BIG PHARMA ACCOUNTABLE, LOWERING DRUG PRICES FOR THE AMERICAN PEOPLE
Aug 12, 2022
Big Pharma Can No Longer Evade Accountability and Keep Prices High by Spending… Read More
CSRXP APPLAUDS SENATE FOR MAJOR STEP TOWARD HOLDING BIG PHARMA ACCOUNTABLE AND LOWERING PRESCRIPTION DRUG PRICES
Aug 7, 2022
Drug Pricing Solutions in Inflation Reduction Act of 2022 Will Help Crack Down… Read More
CSRXP COMMENDS ADVANCEMENT OF BILL TO BOOST AGENCY COOPERATION TO CRACK DOWN ON BIG PHARMA’S PATENT ABUSE
Jul 28, 2022
Bipartisan Interagency Patent Coordination and Improvement Act of 2022 Will… Read More
CSRXP: INSULIN ACT MAY PROVIDE SHORT TERM RELIEF FOR SOME PATIENTS BUT WON’T ADDRESS ROOT CAUSE OF OUT-OF-CONTROL DRUG PRICES
Jul 19, 2022
Congress Must Advance Bipartisan, Market-Based Solutions to Hold Big Pharma… Read More
CSRXP: BIG PHARMA BRAZENLY INCREASES PRICES ON MORE THAN 100 DRUGS TO START JULY PRICE-GOUGING
Jul 12, 2022
Brand Name Drug Companies Begin Second Round of Biannual Price Hikes While… Read More